Cellevolve

Cellevolve

Biotechnology-Research

San Francisco, Calif...
United States
Company Tagline

We believe that patients benefit from breakthrough science ONLY when it’s transformed into commercial treatments

Industry Category
Biotechnology-Research
Company Description

Cellevolve is dedicated to transforming breakthrough science into commercial treatments, ensuring that patients benefit from the latest advancements. With a focus on cell therapies, Cellevolve is at the forefront of revolutionizing disease treatment and improving health outcomes. The company partners with innovators at academic medical centers and small biotechs worldwide to advance clinical-stage therapies through late-stage development and commercialization.

Headquartered in San Francisco, CA, at 535 Mission St, San Francisco, California 94105, US, Cellevolve leverages advances in biology and technology to develop novel therapeutics. Cellevolve is committed to bringing innovative solutions to patients, focusing on rare diseases and cutting-edge biotech advancements. The company’s strategic partnerships and focused approach position it as a key player in the rapidly evolving landscape of cell therapy.

Cellevolve is paving the way for the next generation of cell therapies, with a vision to transform health outcomes globally. By fostering collaboration and driving innovation, Cellevolve aims to make a significant impact on the treatment of diseases. We invite the Cellevolve management team to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development and reach.

Cellevolve se consacre à transformer les découvertes scientifiques en traitements commerciaux, garantissant ainsi que les patients bénéficient des dernières avancées. En mettant l'accent sur les thérapies cellulaires, Cellevolve est à l'avant-garde de la révolution du traitement des maladies et de l'amélioration des résultats en matière de santé. L'entreprise collabore avec des innovateurs dans des centres médicaux universitaires et de petites entreprises biotechnologiques du monde entier pour faire progresser les thérapies en phase clinique jusqu'aux phases finales de développement et de commercialisation.

Basée à San Francisco, CA, au 535 Mission St, San Francisco, Californie 94105, États-Unis, Cellevolve exploite les progrès de la biologie et de la technologie pour développer de nouvelles solutions thérapeutiques. Cellevolve s'engage à apporter des solutions innovantes aux patients, en se concentrant sur les maladies rares et les avancées biotechnologiques de pointe. Les partenariats stratégiques de l'entreprise et son approche ciblée la positionnent comme un acteur clé dans le paysage en évolution rapide de la thérapie cellulaire.

Cellevolve ouvre la voie à la prochaine génération de thérapies cellulaires, avec une vision de transformer les résultats de santé à l'échelle mondiale. En favorisant la collaboration et en stimulant l'innovation, Cellevolve vise à avoir un impact significatif sur le traitement des maladies. Nous invitons l'équipe de direction de Cellevolve à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore leur développement commercial et leur portée.

Key Personnel / Employees
Joyce McGuerty

Compare Companies Side by Side

Compare Cellevolve with 3 companies in Biotechnology-Research

4 Companies
Comparison Field
Cellevolve
Cellevolve
Main Company
BioNTech SE
BioNTech SE
View Profile
Cellaïon
Cellaïon
View Profile
Carmine Therapeutics
Carmine Therapeutics
View Profile
Founded Year
2008 2021 2019
Company Size
1,001-5,000 11-50 11-50
City
San Francisco, California Mainz, Rhineland-Palatinate Mont Saint Guibert, Wallonia Cambridge, Massachusetts
Country
United States Germany Belgium United States
Skills & Keywords Comparing with main company
10 Total Skills
Cell Therapy Biotechnology Rare Diseases Commercial Treatments Clinical Development Biotech Innovation Therapeutics Rare diseases Cell therapy Biotech
13 Total 1 Common 12 Unique
Match 10%
Common Skills:
Biotechnology
Unique Skills:
Antibody therapeutics Bispecific antibodies CAR T Immunotherapy Individualized cancer medicine Infectious diseases +6
12 Total 1 Common 11 Unique
Match 10%
Common Skills:
Biotechnology
Unique Skills:
ACLF Acquired liver diseases Acute liver disease Antibodies Chronic liver disease Clinical stage +5
4 Total 1 Common 3 Unique
Match 10%
Common Skills:
Therapeutics
Unique Skills:
Non-viral gene therapy Platform technologies Red blood cell extracellular vesicles
4
Total Companies
2008
Oldest Founded
3
Countries
36
Unique Skills

Similar Companies

Other organizations in the same industry

Harvard Undergraduate OpenBio Laboratory
Biotechnology-Research

Collaborative community at Harvard using biology to build a better world.

Allston, MA
United States
Lovaltech
Biotechnology-Research

For a pandemic-free world

Tours, Centre-Val de...
France
Hedonix Biosciences
Biotechnology-Research

Living healthier for longer. For more info send a Message to Agustin Blacker at agustinblacker@gmail...

ProteinQure
Biotechnology-Research

Peptide-based drug delivery.

Toronto, Ontario
Canada

Alternative Company Names

This company is also known as

Cellevolve Cellevolve(赛尔沃夫) सेलेवॉल्व سيلفولف Целлевольв